VEGFR-2-IN-6 Catalog No.:M15386-2 CALP3 causes dose-dependent inhibition of

CALP3 causes dose-dependent inhibition of apoptosis (IC50=33

5 mg/kg) has systemic clearance of 32

which binds RIP3 kinase domain with an IC50 of 8

InChiKey: IBCXZJCWDGCXQT-UHFFFAOYSA-N

is a tricyclic antidepressant (TCA) approved in Russia for the treatment of depression

VEGFR-2-IN-6 Catalog No.:M15386-2 CALP3 causes dose-dependent inhibition ofVEGFR 2 IN 6 (example 64) is a VEGFR2 inhibitor (angiogenesis modulator), which is extracted from patent WO 02 059110. Product information CAS Number: 444731 47 9 Molecular Weight: 423. 49 Formula: C20H21N7O2S Chemical Name: 2 methyl 5 ({4 [methyl(3 methyl 1H indazol 6 yl)amino]pyrimidin 2 yl}amino)benzene 1 sulfonamide Smiles: CC1=CC=C(C=C1S(N)(=O)=O)NC1N=C(C=CN=1)N(C)C1=CC2NN=C(C)C=2C=C1 InChiKey: BRBRXNGJZMGEHY UHFFFAOYSA N InChi: InChI=1S